vs

Side-by-side financial comparison of CVRx, Inc. (CVRX) and SOUTHERN FIRST BANCSHARES INC (SFST). Click either name above to swap in a different company.

SOUTHERN FIRST BANCSHARES INC is the larger business by last-quarter revenue ($31.8M vs $16.0M, roughly 2.0× CVRx, Inc.). On growth, SOUTHERN FIRST BANCSHARES INC posted the faster year-over-year revenue change (26.1% vs 4.4%). SOUTHERN FIRST BANCSHARES INC produced more free cash flow last quarter ($29.9M vs $-9.8M). Over the past eight quarters, SOUTHERN FIRST BANCSHARES INC's revenue compounded faster (22.2% CAGR vs 22.0%).

CVRx, Inc. is a commercial-stage medical technology company specializing in neuromodulation therapies for chronic cardiovascular diseases. Its flagship Barostim system treats heart failure and resistant hypertension, with core markets across North America and Europe, serving patients unresponsive to conventional drug treatments.

First Community Bankshares, Inc. is a $2.43 billion bank holding company and the parent company of First Community Bank of Bluefield, Virginia, in the United States. As of 2012 First Community Bank had 45 locations in Virginia, West Virginia, and North Carolina, and two locations operating as Peoples Community Bank in Tennessee. As of April 21, 2023, First Community had $3.6 billion in assets.

CVRX vs SFST — Head-to-Head

Bigger by revenue
SFST
SFST
2.0× larger
SFST
$31.8M
$16.0M
CVRX
Growing faster (revenue YoY)
SFST
SFST
+21.7% gap
SFST
26.1%
4.4%
CVRX
More free cash flow
SFST
SFST
$39.7M more FCF
SFST
$29.9M
$-9.8M
CVRX
Faster 2-yr revenue CAGR
SFST
SFST
Annualised
SFST
22.2%
22.0%
CVRX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CVRX
CVRX
SFST
SFST
Revenue
$16.0M
$31.8M
Net Profit
$-11.9M
Gross Margin
86.3%
Operating Margin
-69.8%
40.1%
Net Margin
-74.5%
Revenue YoY
4.4%
26.1%
Net Profit YoY
-12.0%
EPS (diluted)
$-0.45
$1.19

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CVRX
CVRX
SFST
SFST
Q4 25
$16.0M
$31.8M
Q3 25
$14.7M
$31.1M
Q2 25
$13.6M
$28.6M
Q1 25
$12.3M
$26.5M
Q4 24
$15.3M
$25.2M
Q3 24
$13.4M
$23.8M
Q2 24
$11.8M
$23.1M
Q1 24
$10.8M
$21.3M
Net Profit
CVRX
CVRX
SFST
SFST
Q4 25
$-11.9M
Q3 25
$-12.9M
$8.7M
Q2 25
$-14.7M
$6.6M
Q1 25
$-13.8M
$5.3M
Q4 24
$-10.7M
Q3 24
$-13.1M
$4.4M
Q2 24
$-14.0M
$3.0M
Q1 24
$-22.2M
$2.5M
Gross Margin
CVRX
CVRX
SFST
SFST
Q4 25
86.3%
Q3 25
86.8%
Q2 25
84.3%
Q1 25
83.5%
Q4 24
83.2%
Q3 24
83.2%
Q2 24
83.9%
Q1 24
85.0%
Operating Margin
CVRX
CVRX
SFST
SFST
Q4 25
-69.8%
40.1%
Q3 25
-83.5%
36.4%
Q2 25
-105.8%
30.0%
Q1 25
-108.8%
26.1%
Q4 24
-67.0%
27.3%
Q3 24
-97.3%
24.1%
Q2 24
-118.3%
17.0%
Q1 24
-206.4%
15.9%
Net Margin
CVRX
CVRX
SFST
SFST
Q4 25
-74.5%
Q3 25
-87.6%
27.8%
Q2 25
-108.4%
23.0%
Q1 25
-111.5%
19.9%
Q4 24
-69.4%
Q3 24
-98.0%
18.4%
Q2 24
-118.8%
13.0%
Q1 24
-206.0%
11.8%
EPS (diluted)
CVRX
CVRX
SFST
SFST
Q4 25
$-0.45
$1.19
Q3 25
$-0.49
$1.07
Q2 25
$-0.57
$0.81
Q1 25
$-0.53
$0.65
Q4 24
$-0.39
$0.69
Q3 24
$-0.57
$0.54
Q2 24
$-0.65
$0.37
Q1 24
$-1.04
$0.31

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CVRX
CVRX
SFST
SFST
Cash + ST InvestmentsLiquidity on hand
$75.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$39.3M
$368.7M
Total Assets
$104.8M
$4.4B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CVRX
CVRX
SFST
SFST
Q4 25
$75.7M
Q3 25
$85.1M
Q2 25
$95.0M
Q1 25
$102.7M
Q4 24
$105.9M
Q3 24
$100.2M
Q2 24
$70.4M
Q1 24
$80.1M
Stockholders' Equity
CVRX
CVRX
SFST
SFST
Q4 25
$39.3M
$368.7M
Q3 25
$48.1M
$356.3M
Q2 25
$57.9M
$345.5M
Q1 25
$71.1M
$337.6M
Q4 24
$71.1M
$330.4M
Q3 24
$65.2M
$326.5M
Q2 24
$55.2M
$318.7M
Q1 24
$66.3M
$315.3M
Total Assets
CVRX
CVRX
SFST
SFST
Q4 25
$104.8M
$4.4B
Q3 25
$111.3M
$4.4B
Q2 25
$119.6M
$4.3B
Q1 25
$129.6M
$4.3B
Q4 24
$133.4M
$4.1B
Q3 24
$127.7M
$4.2B
Q2 24
$96.0M
$4.1B
Q1 24
$106.2M
$4.1B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CVRX
CVRX
SFST
SFST
Operating Cash FlowLast quarter
$-9.8M
$30.5M
Free Cash FlowOCF − Capex
$-9.8M
$29.9M
FCF MarginFCF / Revenue
-61.3%
93.8%
Capex IntensityCapex / Revenue
0.4%
1.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-40.8M
$62.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CVRX
CVRX
SFST
SFST
Q4 25
$-9.8M
$30.5M
Q3 25
$-9.7M
$14.5M
Q2 25
$-7.9M
$10.5M
Q1 25
$-12.8M
$7.6M
Q4 24
$-8.0M
$25.6M
Q3 24
$-10.4M
$26.3M
Q2 24
$-9.8M
$4.0M
Q1 24
$-10.9M
$-2.9M
Free Cash Flow
CVRX
CVRX
SFST
SFST
Q4 25
$-9.8M
$29.9M
Q3 25
$-10.0M
$14.4M
Q2 25
$-8.0M
$10.4M
Q1 25
$-12.9M
$7.4M
Q4 24
$-8.1M
$24.8M
Q3 24
$-10.4M
$26.1M
Q2 24
$-10.2M
$3.9M
Q1 24
$-11.8M
$-3.2M
FCF Margin
CVRX
CVRX
SFST
SFST
Q4 25
-61.3%
93.8%
Q3 25
-68.1%
46.3%
Q2 25
-59.2%
36.3%
Q1 25
-104.3%
28.1%
Q4 24
-52.5%
98.2%
Q3 24
-78.1%
110.0%
Q2 24
-86.3%
16.8%
Q1 24
-109.7%
-15.0%
Capex Intensity
CVRX
CVRX
SFST
SFST
Q4 25
0.4%
1.8%
Q3 25
2.0%
0.3%
Q2 25
0.8%
0.3%
Q1 25
0.9%
0.5%
Q4 24
0.3%
3.1%
Q3 24
0.3%
0.8%
Q2 24
3.0%
0.4%
Q1 24
8.5%
1.3%
Cash Conversion
CVRX
CVRX
SFST
SFST
Q4 25
Q3 25
1.67×
Q2 25
1.59×
Q1 25
1.44×
Q4 24
Q3 24
6.01×
Q2 24
1.32×
Q1 24
-1.16×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CVRX
CVRX

US$14.9M93%
Other$1.1M7%

SFST
SFST

Segment breakdown not available.

Related Comparisons